Importance of including early nonadherence in estimations of medication adherence;Importancia de incluir la no-adherencia temprana en los estimados de adherencia a medicamentos

Annals of Pharmacotherapy

Volumn 45, Issue 9, 2011, Pages 1053-1060

  Raebel, Marsha A ^a,b   Carroll, Nikki M ^a   Ellis, Jennifer L ^a   Schroeder, Emily B ^a,c   Bayliss, Elizabeth A ^a,c  

^a KAISER PERMANENTE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Adherence inflation; Early nonpersistence; Medication adherence; Primary nonadherence

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT;

ARTICLE; COHORT ANALYSIS; DATA BASE; DIABETES MELLITUS; HEALTH CARE DELIVERY; HEALTH CARE SYSTEM; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT REFUSAL;

ANTIHYPERTENSIVE AGENTS; COHORT STUDIES; DATABASES, FACTUAL; HUMANS; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; MEDICATION ADHERENCE; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 80052485513     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1Q146     Document Type: Article

References (28)

1. Balkrishnan R. The importance of medication adherence in improving chronic-disease related outcomes: what we know and what we need to further know. Med Care 2005;43:517-20
2. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005; 353:487-97
3. Walker EA, Molitch M, Kramer MK, et al. Adherence to preventive medications: predictors and outcomes in the Diabetes Prevention Program. Diabetes Care 2006;29:1997-2002. DOI 10.2337/dc06-0454
4. Wu JR, Moser DK, DeJong MJ, et al. Defining an evidence-based cut point for medication adherence in heart failure. Am Heart J 2009;157: 285-91. DOI 10.1016/j.ahj.2008.10.001
5. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005;43:521-30
6. Ho PM, Magid DJ, Shetterly SM, et al. Importance of therapy intensification and medication nonadherence for blood pressure control in patients with coronary disease. Arch Intern Med 2008;168:271-6
7. McGinnis BD, Olson KL, Delate TMA, Stolcpart RS. Statin adherence and mortality in patients enrolled in a secondary prevention program. Am J Manag Care 2009;15:689-95.
8. Roebuck MC, Liberman JN, Gemmill-Toyama M, Brennan TA. Medicaion adherence leads to lower health care use and costs despite increased drug spending. Health Aff 2011;30:91-9. DOI 10.1377/hlthaff.2009.1087
9. Yeaw J, Benner JS, Walt JG, Sian S, Smith DB. Comparing adherence and persistence across 6 chronic medication classes. J Manag Care Pharm 2009;15:728-40.
10. Yoon J, Ettner SL. Cost-sharing and adherence to antihypertensives for low and high adherers. Am J Manag Care 2009;15:833-40.
11. Sheehan DV, Keene MS, Eaddy M, Krulewicz S, Kraus JE, Carpenter DJ. Difference in adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders. CNS Drugs 2008;22:963-73.
12. Briesacher BA, Andrade SE, Fouayzi H, Chan KA. Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy 2008;28:437-43.
13. Raebel MA, Charles J, Dugan J, et al. Randomized trial to improve prescribing safety among ambulatory elderly patients. J Am Geriatr Soc 2007;55:977-85. DOI 10.1111/j.1532-5415.2007.01202.x
14. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol 1997;50:105-16.
15. Halpern R, Becker L, Iqbal SU, Kazis LE, Macarios D, Badamgarav E. The association of adherence to osteoporosis therapies with fracture, allcause medical costs, and all-cause hospitalizations: a retrospective claims analysis of female health plan enrollees with osteoporosis. J Manag Care Pharm 2011;17:25-39.
16. Raebel MA, Delate T, Ellis JL, Bayliss EA. Effects of reaching the drug benefit threshold on Medicare members' healthcare utilization during the first year of Medicare Part D. Med Care 2008;46:1116-22.
17. Andrade SE, Kahler KH, Frech F, Chan KA. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf 2006;15:565-74. DOI 10.1002/pds.1230
18. Hess LM, Raebel MA, Conner DA, Malone DC. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother 2006;40:1280-8. DOI 10.1345/aph.1H018
19. Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA 2002;288:455-61. DOI 10.1001/jama.288.4.455
20. Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med 2006;166:1836-41.
21. Hansen RA, Kim MM, Song L, Tu W, Jingwei W, Murray MD. Comparison of methods to assess medication adherence and classify nonadherence. Ann Pharmacother 2009;43:413-22. DOI 10.1345/aph.1L496
22. Barker N. A practical introduction to the bootstrap using the SAS system. Proceedings of PhUse 2005. October 10-12, 2005, Heidelberg, Germany. http://www.lexjansen.com/phuse/2005/pk/pk02.pdf (accessed 2011 Jun 17).
23. Chan DC, Shrank WH, Cutler D, et al. Patient, physician, and payment predictors of statin adherence. Med Care 2010;48:196-202.
24. Karter AJ, Parker MM, Moffet HH, Ahmed AM, Schmittdiel JA, Selby JV. New prescription medication gaps: a comprehensive measure of adherence to new prescriptions. Health Services Research 2009;44:1640-61. DOI 10.1111/j.1475-6773.2009.00989.x
25. Hertz RP, Unger AN, Lustik MB. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employersponsored health insurance. Clin Ther 2005;27:1064-73. DOI l0.1016/j.clinthera.2005.07.009
26. Shah NR, Hirsch AG, Zacker C, Taylor S, Wood GC, Stewart WF. Factors associated with first-fill adherence rates for diabetic medications: a cohort study. J Gen Intern Med 2009;24:233-7. DOI 10.1007/s11606-008-0870-z
27. Fischer MA, Stedman MR, Lii J, et al. Primary medication non-adherence: analysis of 195,930 electronic prescriptions. J Gen Intern Med 2010;25:284-90. DOI 10.1007/s11606-010-1253-9
28. Karter AJ, Parker MM, Adams AS, et al. Primary non-adherence to prescribed medications. J Gen Intern Med 2010;25:763. DOI 10.1007/s11606-010-1381-2